Whalesbook
West Asia Conflict Hits IPO Market
Escalating conflict in West Asia is hurting India's primary market, reducing investor enthusiasm for initial public offerings (IPOs). This cautious sentiment, visible in the secondary market's sharp sell-off, has directly affected subscription levels for several public issues that opened on March 24.
Amir Chand IPO Success, Others Fall Short
Amir Chand Jagdish Kumar's IPO was the only success among three mainboard offerings seeking to raise a combined ₹1,948.79 crore. The issue was subscribed 2.09 times, mainly driven by strong demand from non-institutional investors (NIIs), who oversubscribed their portion by 7.80 times. However, allocations for qualified institutional buyers (QIBs) and retail investors were undersubscribed, showing caution even from typically eager participants.
Powerica and Sai Parenteral See Low Demand
In contrast, demand for Powerica and Sai Parenteral's IPOs was muted. By Friday afternoon, Powerica's issue was only 5% subscribed. Sai Parenteral's offering fared slightly better but reached just 50% subscription, according to NSE data. This weak performance highlights the IPO market's sensitivity to broader economic and geopolitical uncertainties.
Market Sell-off Impacts IPO Interest
The weak IPO response is tied to the sharp correction in Indian equity benchmarks. The BSE Sensex fell 1,172 points (1.56%) to 74,101, and the NSE Nifty 50 dropped 344 points (1.48%) to 22,962. This broad market decline reduces investor confidence and liquidity, making investors hesitant to put capital into new ventures.
Analysts Offer Mixed Ratings
Brokerage firms provided mixed recommendations, reflecting varied investment views and market conditions. SBI Securities advised a 'Subscribe' for Amir Chand Jagdish Kumar long-term, citing growth. Swastika Investmart recommended 'Avoid' due to valuation concerns, despite noting business momentum. For Powerica, SBI Securities also suggested a long-term subscription, while Swastika Investmart advised limited exposure for risk-tolerant investors. Sai Parenteral received mixed reviews, with SBI Securities and Ashika Institutional Equities recommending 'Subscribe,' while Swastika Investmart rated it 'Avoid.'
Grey Market Premiums Show Weak Conviction
Unofficial grey market trends reflect the caution. Amir Chand Jagdish Kumar shares traded at a modest premium of about 3.30% over its upper price band. Sai Parenteral's shares were flat, at the upper limit of its price band. Powerica's IPO saw only a small premium of around 0.25% in the grey market, indicating weak investor confidence for these new listings.